private:enginebio
|
6416170
|
Nov 18th, 2019 12:00AM
|
Engine Biosciences
|
745
|
24.00
|
Open
|
Biotechnology
|
Nov 18th, 2019 04:12PM
|
Nov 18th, 2019 04:12PM
|
Engine Biosciences is a venture-backed San Francisco- and Asia-based technology company pioneering network biomedicine. Our proprietary and patented technologies oriented around deciphering the complexity of biology networks include both high-throughput wet lab experimentation and artificial intelligence algorithms for drug discovery and cellular reprogramming. This platform, developed through several years of research by our scientific founding and leadership team who include faculty members at MIT, Harvard, Mayo Clinic, and UCSD, dramatically accelerates and reduces costs of the R&D process for new medical therapies. We are actively applying the platform internally and with partners across a range of disease indications.
In January 2018, we announced the closing of a US$10M seed round from notable biotech and tech institutional investors and are expanding the team.
|
Open
|
|
Open
|
160 Robinson Road, #23-02
|
Singapore
|
Singapore
|
SG
|
068914
|
|
Engine Biosciences
|
|
|
private:enginebio
|
6416170
|
Nov 17th, 2019 12:00AM
|
Engine Biosciences
|
743
|
24.00
|
Open
|
Biotechnology
|
Nov 17th, 2019 04:38PM
|
Nov 17th, 2019 04:38PM
|
Engine Biosciences is a venture-backed San Francisco- and Asia-based technology company pioneering network biomedicine. Our proprietary and patented technologies oriented around deciphering the complexity of biology networks include both high-throughput wet lab experimentation and artificial intelligence algorithms for drug discovery and cellular reprogramming. This platform, developed through several years of research by our scientific founding and leadership team who include faculty members at MIT, Harvard, Mayo Clinic, and UCSD, dramatically accelerates and reduces costs of the R&D process for new medical therapies. We are actively applying the platform internally and with partners across a range of disease indications.
In January 2018, we announced the closing of a US$10M seed round from notable biotech and tech institutional investors and are expanding the team.
|
Open
|
|
Open
|
160 Robinson Road, #23-02
|
Singapore
|
Singapore
|
SG
|
068914
|
|
Engine Biosciences
|
|
|
private:enginebio
|
6416170
|
Nov 16th, 2019 12:00AM
|
Engine Biosciences
|
741
|
24.00
|
Open
|
Biotechnology
|
Nov 16th, 2019 04:32PM
|
Nov 16th, 2019 04:32PM
|
Engine Biosciences is a venture-backed San Francisco- and Asia-based technology company pioneering network biomedicine. Our proprietary and patented technologies oriented around deciphering the complexity of biology networks include both high-throughput wet lab experimentation and artificial intelligence algorithms for drug discovery and cellular reprogramming. This platform, developed through several years of research by our scientific founding and leadership team who include faculty members at MIT, Harvard, Mayo Clinic, and UCSD, dramatically accelerates and reduces costs of the R&D process for new medical therapies. We are actively applying the platform internally and with partners across a range of disease indications.
In January 2018, we announced the closing of a US$10M seed round from notable biotech and tech institutional investors and are expanding the team.
|
Open
|
|
Open
|
160 Robinson Road, #23-02
|
Singapore
|
Singapore
|
SG
|
068914
|
|
Engine Biosciences
|
|
|
private:enginebio
|
6416170
|
Nov 15th, 2019 12:00AM
|
Engine Biosciences
|
740
|
24.00
|
Open
|
Biotechnology
|
Nov 15th, 2019 01:12PM
|
Nov 15th, 2019 01:12PM
|
Engine Biosciences is a venture-backed San Francisco- and Asia-based technology company pioneering network biomedicine. Our proprietary and patented technologies oriented around deciphering the complexity of biology networks include both high-throughput wet lab experimentation and artificial intelligence algorithms for drug discovery and cellular reprogramming. This platform, developed through several years of research by our scientific founding and leadership team who include faculty members at MIT, Harvard, Mayo Clinic, and UCSD, dramatically accelerates and reduces costs of the R&D process for new medical therapies. We are actively applying the platform internally and with partners across a range of disease indications.
In January 2018, we announced the closing of a US$10M seed round from notable biotech and tech institutional investors and are expanding the team.
|
Open
|
|
Open
|
160 Robinson Road, #23-02
|
Singapore
|
Singapore
|
SG
|
068914
|
|
Engine Biosciences
|
|
|
private:enginebio
|
6416170
|
Nov 13th, 2019 12:00AM
|
Engine Biosciences
|
739
|
24.00
|
Open
|
Biotechnology
|
Nov 13th, 2019 01:33PM
|
Nov 13th, 2019 01:33PM
|
Engine Biosciences is a venture-backed San Francisco- and Asia-based technology company pioneering network biomedicine. Our proprietary and patented technologies oriented around deciphering the complexity of biology networks include both high-throughput wet lab experimentation and artificial intelligence algorithms for drug discovery and cellular reprogramming. This platform, developed through several years of research by our scientific founding and leadership team who include faculty members at MIT, Harvard, Mayo Clinic, and UCSD, dramatically accelerates and reduces costs of the R&D process for new medical therapies. We are actively applying the platform internally and with partners across a range of disease indications.
In January 2018, we announced the closing of a US$10M seed round from notable biotech and tech institutional investors and are expanding the team.
|
Open
|
|
Open
|
160 Robinson Road, #23-02
|
Singapore
|
Singapore
|
SG
|
068914
|
|
Engine Biosciences
|
|
|
private:enginebio
|
6416170
|
Nov 12th, 2019 12:00AM
|
Engine Biosciences
|
739
|
24.00
|
Open
|
Biotechnology
|
Nov 12th, 2019 03:15PM
|
Nov 12th, 2019 03:15PM
|
Engine Biosciences is a venture-backed San Francisco- and Asia-based technology company pioneering network biomedicine. Our proprietary and patented technologies oriented around deciphering the complexity of biology networks include both high-throughput wet lab experimentation and artificial intelligence algorithms for drug discovery and cellular reprogramming. This platform, developed through several years of research by our scientific founding and leadership team who include faculty members at MIT, Harvard, Mayo Clinic, and UCSD, dramatically accelerates and reduces costs of the R&D process for new medical therapies. We are actively applying the platform internally and with partners across a range of disease indications.
In January 2018, we announced the closing of a US$10M seed round from notable biotech and tech institutional investors and are expanding the team.
|
Open
|
|
Open
|
160 Robinson Road, #23-02
|
Singapore
|
Singapore
|
SG
|
068914
|
|
Engine Biosciences
|
|
|
private:enginebio
|
6416170
|
Nov 11th, 2019 12:00AM
|
Engine Biosciences
|
739
|
24.00
|
Open
|
Biotechnology
|
Nov 11th, 2019 03:13PM
|
Nov 11th, 2019 03:13PM
|
Engine Biosciences is a venture-backed San Francisco- and Asia-based technology company pioneering network biomedicine. Our proprietary and patented technologies oriented around deciphering the complexity of biology networks include both high-throughput wet lab experimentation and artificial intelligence algorithms for drug discovery and cellular reprogramming. This platform, developed through several years of research by our scientific founding and leadership team who include faculty members at MIT, Harvard, Mayo Clinic, and UCSD, dramatically accelerates and reduces costs of the R&D process for new medical therapies. We are actively applying the platform internally and with partners across a range of disease indications.
In January 2018, we announced the closing of a US$10M seed round from notable biotech and tech institutional investors and are expanding the team.
|
Open
|
|
Open
|
160 Robinson Road, #23-02
|
Singapore
|
Singapore
|
SG
|
068914
|
|
Engine Biosciences
|
|
|
private:enginebio
|
6416170
|
Nov 10th, 2019 12:00AM
|
Engine Biosciences
|
739
|
23.00
|
Open
|
Biotechnology
|
Nov 10th, 2019 06:20PM
|
Nov 10th, 2019 06:20PM
|
Engine Biosciences is a venture-backed San Francisco- and Asia-based technology company pioneering network biomedicine. Our proprietary and patented technologies oriented around deciphering the complexity of biology networks include both high-throughput wet lab experimentation and artificial intelligence algorithms for drug discovery and cellular reprogramming. This platform, developed through several years of research by our scientific founding and leadership team who include faculty members at MIT, Harvard, Mayo Clinic, and UCSD, dramatically accelerates and reduces costs of the R&D process for new medical therapies. We are actively applying the platform internally and with partners across a range of disease indications.
In January 2018, we announced the closing of a US$10M seed round from notable biotech and tech institutional investors and are expanding the team.
|
Open
|
|
Open
|
160 Robinson Road, #23-02
|
Singapore
|
Singapore
|
SG
|
068914
|
|
Engine Biosciences
|
|
|
private:enginebio
|
6416170
|
Nov 9th, 2019 12:00AM
|
Engine Biosciences
|
739
|
23.00
|
Open
|
Biotechnology
|
Nov 9th, 2019 05:47PM
|
Nov 9th, 2019 05:47PM
|
Engine Biosciences is a venture-backed San Francisco- and Asia-based technology company pioneering network biomedicine. Our proprietary and patented technologies oriented around deciphering the complexity of biology networks include both high-throughput wet lab experimentation and artificial intelligence algorithms for drug discovery and cellular reprogramming. This platform, developed through several years of research by our scientific founding and leadership team who include faculty members at MIT, Harvard, Mayo Clinic, and UCSD, dramatically accelerates and reduces costs of the R&D process for new medical therapies. We are actively applying the platform internally and with partners across a range of disease indications.
In January 2018, we announced the closing of a US$10M seed round from notable biotech and tech institutional investors and are expanding the team.
|
Open
|
|
Open
|
160 Robinson Road, #23-02
|
Singapore
|
Singapore
|
SG
|
068914
|
|
Engine Biosciences
|
|
|
private:enginebio
|
6416170
|
Nov 8th, 2019 12:00AM
|
Engine Biosciences
|
739
|
23.00
|
Open
|
Biotechnology
|
Nov 8th, 2019 02:58PM
|
Nov 8th, 2019 02:58PM
|
Engine Biosciences is a venture-backed San Francisco- and Asia-based technology company pioneering network biomedicine. Our proprietary and patented technologies oriented around deciphering the complexity of biology networks include both high-throughput wet lab experimentation and artificial intelligence algorithms for drug discovery and cellular reprogramming. This platform, developed through several years of research by our scientific founding and leadership team who include faculty members at MIT, Harvard, Mayo Clinic, and UCSD, dramatically accelerates and reduces costs of the R&D process for new medical therapies. We are actively applying the platform internally and with partners across a range of disease indications.
In January 2018, we announced the closing of a US$10M seed round from notable biotech and tech institutional investors and are expanding the team.
|
Open
|
|
Open
|
160 Robinson Road, #23-02
|
Singapore
|
Singapore
|
SG
|
068914
|
|
Engine Biosciences
|
|
|